Insulin Delivery Devices Market Size Forecasted To Achieve $26.3 Billion By 2029 With Steady Growth

The Insulin Delivery Devices Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Insulin Delivery Devices Market Size and Projected Growth Rate?
The insulin delivery devices market size has grown strongly in recent years. It will grow from $17.71 billion in 2024 to $19.22 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to the convenience and ease of use offered by insulin delivery devices, favorable reimbursement policies, increasing prevalence of obesity, growing aging population, and increasing adoption of insulin pumps.

The insulin delivery devices market is expected to see strong growth in the next few years, projected to reach $26.3 billion by 2029 at a CAGR of 8.2%. This growth is driven by the rising prevalence of diabetes, increasing healthcare expenditure on diabetes care, the adoption of continuous glucose monitoring systems, growing awareness about automated insulin delivery devices, and increased focus on healthcare. Key trends include technological advancements in insulin delivery devices, integration of digital technology, development of artificial pancreas systems, and innovations in insulin administration technology.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18642

What Are the Major Segments in the Insulin Delivery Devices Market?
The insulin delivery devices market covered in this report is segmented -

1) By Type: Insulin Syringes, Insulin Jet Injectors, Pen Needles, Reusable Insulin Pens, Disposable Insulin Pens, Insulin Pumps, External Or Tethered Pumps, Patch Pumps
2) By Disease Indication: Type 1, Type 2
3) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics Or Centers

Subsegments:
1) By Insulin Syringes: Standard Insulin Syringes, Insulin Syringes With Fixed Or Adjustable Needle Length
2) By Insulin Jet Injectors: Needle-Free Insulin Jet Injectors, High-Pressure Insulin Jet Injectors
3) By Pen Needles: Short Pen Needles, Long Pen Needles
4) By Reusable Insulin Pens: Reusable Pens With Replaceable Cartridges, Refillable Insulin Pens
5) By Disposable Insulin Pens: Single-Use Disposable Insulin Pens, Pre-Filled Disposable Insulin Pens
6) By Insulin Pumps: Traditional Insulin Pumps, Smart Insulin Pumps
7) By External Or Tethered Pumps: Traditional External Insulin Pumps, Wireless Tethered Pumps
8) By Patch Pumps: Patch Insulin Pumps, Integrated Patch Pumps

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18642&type=smp

What Are The Driving Insulin Delivery Devices Market Evolution?
The rising incidence of diabetes is expected to accelerate the insulin delivery devices market. Diabetes is a long-term health condition characterized by high blood sugar levels due to insufficient insulin production or improper use by the body. Contributing factors include sedentary behavior, unhealthy eating habits, and the global rise in obesity. Insulin delivery devices are vital for helping people manage diabetes effectively by delivering insulin in a safe and convenient way, preventing complications and supporting overall health. For example, in December 2022, the Centers for Disease Control and Prevention reported that by 2060, the number of U.S. youths under 20 with type 2 diabetes may rise by nearly 700%, reaching around 220,000, while type 1 diabetes cases could grow by 65%. Thus, the increasing diabetes burden is propelling the insulin delivery devices market.

Which Firms Dominate The Insulin Delivery Devices Market Segments?
Major companies operating in the insulin delivery devices market are Sanofi SA, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Medtronic Plc, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, EOFlow Co. Ltd., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Xeris Pharmaceuticals Inc., Beta Bionics Inc., Zealand Pharma AS, Bigfoot Biomedical Inc., Emperra GmbH, Animas Corporation, Debiotech SA, CeQur Corporation, Aerami Therapeutics Inc., Alshifa Medical Group, AMF Medical SA, Andain Inc., Avecho Biotechnology Ltd., Apex Medical Devices

What Insulin Delivery Devices Market Trends Are Gaining Traction Across Different Segments?
Leading firms in the insulin delivery devices market are leveraging innovation to produce products like insulin pumps that deliver insulin in a continuous or customizable fashion. An insulin pump, a programmable medical device, delivers insulin on a continuous basis or as needed via a catheter inserted beneath the skin. For example, in May of 2023, Beta Bionics, an American medical tech company, received approval from the U.S. Food and Drug Administration for its iLet ACE Pump and the iLet Dosing Decision Software. The iLet Bionic Pancreas system is meant to assist individuals aged six or older diagnosed with type 1 diabetes by merging two devices with an FDA-approved integrated continuous glucose monitor (iCGM). It is designed to function on an automated insulin dosing (AID) system controlled by an adaptive closed-loop algorithm that initially requires only the user's body weight for setup and gets rid of the need for additional insulin dosing parameters. This system differs from traditional pump therapy as it doesn't require manual adjustment of settings, thereby making it simpler to start and operate. The iLet device also introduces a feature that simplifies insulin dosing during meals by classifying meals as small, medium, or large. Over time, the algorithm learns and adjusts to individual insulin needs.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

Which Is The Largest Region In The Insulin Delivery Devices Market?
North America was the largest region in the insulin delivery devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Insulin Delivery Devices Market?
2. What is the CAGR expected in the Insulin Delivery Devices Market?
3. What Are the Key Innovations Transforming the Insulin Delivery Devices Industry?
4. Which Region Is Leading the Insulin Delivery Devices Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.